Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 123389
Published online Aug 15, 2026. doi: 10.4239/wjd.123389
Published online Aug 15, 2026. doi: 10.4239/wjd.123389
Table 2 Intergroup comparison of blood glucose and lipid levels, mean ± SD
| OP group (n = 134) | Non-OP group (n = 81) | t | P value | |
| FBG | 8.59 ± 2.83 | 7.21 ± 3.13 | 1.917 | 0.057 |
| HbA1c (%) | 9.67 ± 2.96 | 5.32 ± 0.85 | 2.198 | 0.029 |
| TC | 3.97 ± 0.77 | 4.52 ± 0.58 | 0.562 | 0.575 |
| TG | 1.28 ± 0.39 | 1.77 ± 0.97 | 0.351 | 0.726 |
| LDL-C | 2.01 ± 0.65 | 2.27 ± 0.76 | 0.581 | 0.562 |
| HDL-C | 1.03 ± 0.26 | 1.04 ± 0.29 | 0.858 | 0.392 |
| 1,25(OH)2D3 | 15.53 ± 8.70 | 15.09 ± 6.34 | 0.393 | 0.695 |
- Citation: Lu HL, Yu F, Zhou HF, Hu P, Gan SL. Clinical significance of bone metabolic markers in osteoporosis-complicated type 2 diabetes mellitus and risk determinants: A retrospective study. World J Diabetes 2026; 17(8): 123389
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/123389.htm
- DOI: https://dx.doi.org/10.4239/wjd.123389